Development of an Immune-Related Risk Signature in Patients with Bladder Urothelial Carcinoma

With recent advances in immunooncology and tumor microenvironment, the treatment landscape of bladder urothelial carcinoma has been changing dramatically. We aim to construct an immune gene-related signature which can predict BLCA patients' overall survival. Transcriptomic data of BLCA patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yaofei, Wang, Yibing, Li, Cong, Zou, Zhenhong, Liang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455840/
https://www.ncbi.nlm.nih.gov/pubmed/32884943
http://dx.doi.org/10.1155/2020/5848493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455840/
https://www.ncbi.nlm.nih.gov/pubmed/32884943
http://dx.doi.org/10.1155/2020/5848493

Ejemplares similares